Page 134 - 2018_12-Haematologica-web

A.A. Mensah et al.
induce PRMT5 translation and H3R8/H4R3
methylation in mantle cell lymphoma.
EMBO J. 2007;26(15):3558-3569.
40. Arribas AJ, Gomez-Abad C, Sanchez-Beato M, et al. Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling. Mod Pathol.
2013;26(7):889-901.
41. Baraniskin A, Kuhnhenn J, Schlegel U, et al.
Identification of microRNAs in the cere- brospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nerv- ous system. Blood. 2011;117(11):3140-3146.
42. Junker F, Chabloz A, Koch U, Radtke F. Dicer1 imparts essential survival cues in Notch-driven T-ALL via miR-21-mediated tumor suppressor Pdcd4 repression. Blood. 2015;126(8):993-1004.
43. Go H, Jang JY, Kim PJ, et al. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT path- way in diffuse large B-cell lymphoma. Oncotarget. 2015;6(17):15035-15049.
44. BaiH,WeiJ,DengC,YangX,WangC,Xu
R. MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen. Int J Hematol. 2013;97(2):223-231.
45. Iqbal J, Shen Y, Huang X, et al. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood. 2015;125(7):1137-1145.
46. Lawrie CH, Soneji S, Marafioti T, et al. MicroRNA expression distinguishes between germinal center B cell-like and acti- vated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007;121(5):1156-1161.
47. Cimmino A, Calin GA, Fabbri M, et al. miR- 15 and miR-16 induce apoptosis by target- ing BCL2. Proc Natl Acad Sci USA. 2005;102(39):13944-13949.
48. Bartel DP. MicroRNAs: genomics, biogene- sis, mechanism, and function. Cell. 2004;116(2):281-297.
49. Alinari L, Mahasenan KV, Yan F, et al. Selective inhibition of protein arginine
methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood. 2015;125(16):2530-2543.
50. Suzuki HI, Young RA, Sharp PA. Super- enhancer-mediated RNA processing revealed by integrative MicroRNA network analysis. Cell. 2017;168(6):1000-1014. e1015.
51. Ahmadvand M, Eskandari M, Pashaiefar H, et al. Over expression of circulating miR- 155 predicts prognosis in diffuse large B-cell lymphoma. Leuk Res. 2018;70:45-48.
52. Rao E, Jiang C, Ji M, et al. The miRNA-17- 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lym- phoma via PI3K/AKT pathway activation. Leukemia. 2012;26(5):1064-1072.
53. Benhamou D, Labi V, Novak R, et al. A c- Myc/miR17-92/Pten axis controls PI3K-medi- ated positive and negative selection in B cell development and reconstitutes CD19 defi- ciency. Cell Rep. 2016;16(2):419-431.
54. Hnisz D, Abraham BJ, Lee TI, et al. Super- enhancers in the control of cell identity and disease. Cell. 2013;155(4):934-947.
2058
haematologica | 2018; 103(12)